Related Experiment Video
Updated: Apr 14, 2026
05:44
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
1.2K
Thrombosis in vasculitis: from pathogenesis to treatment
Giacomo Emmi1, Elena Silvestri1, Danilo Squatrito1
1Department of Experimental and Clinical Medicine, University of Florence, L.go G. Brambilla, 3, 50134 Florence, Italy.
Thrombosis Journal
|April 18, 2015
Summary
Inflammation and thrombosis are linked, especially in active systemic vasculitides like Behçet's syndrome. Aggressive anti-inflammatory treatment may prevent thrombotic events in these conditions.
Area of Science:
- Rheumatology and Immunology
- Hematology and Coagulation
Background:
- The interplay between the immune and coagulation systems is increasingly recognized.
- Inflammation-induced thrombosis is a key feature of active autoimmune rheumatic diseases and systemic vasculitides.
Purpose of the Study:
- To review the pathogenesis and clinical aspects of thrombosis in vasculitides.
- To provide insights for specialists managing patients with Behçet's syndrome, ANCA-associated vasculitis, and large-vessel vasculitis.
Main Methods:
- Literature review focusing on inflammation, immune system, coagulation, and vasculitis.
- Analysis of pathogenetic mechanisms linking inflammation to thrombosis in specific vasculitic conditions.
Main Results:
- Systemic vasculitides, including Behçet's syndrome, ANCA-associated vasculitis, and giant cell arteritis, exhibit inflammation-induced thrombosis during active disease.
- Treatment strategies for vascular involvement in Behçet's syndrome prioritize immunosuppression over anticoagulation or antiplatelet therapy.
Conclusions:
- Aggressive anti-inflammatory treatment is crucial for managing active vasculitis and may reduce thrombotic risk.
- Understanding the link between inflammation and thrombosis is vital for effective patient management across various vasculitic syndromes.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
724
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
724
01:29Venous Thrombosis III: Interprofessional Care
471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
01:16Clot Retraction and Fibrinolysis
10.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.4K
01:30Venous Thrombosis IV: Nursing Management
397
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
397
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.8K